• Home
  • MF Research
  • Motilal Oswal Nifty MidSmall Healthcare Index Fund-Regular Plan-Growth

Motilal Oswal Nifty MidSmall Healthcare Index Fund-Regular Plan-Growth

arrow-down
NAV
₹ 9.9851 ₹ -0.02 (-0.22 %)
as on 28-05-2025
Asset Size (AUM)
24.19 Cr
Launch Date
Nov 19, 2024
Investment Objective
The scheme seeks to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error.
Minimum Investment 0.0
Minimum Top-up 0.0
Investment Returns Since Launch in Nov 19, 2024
arrow-up

-1.85

%
3 M
6 M
1 Y
3 Y
10 Y
Inception
Sharp Ratio
0.0 %
Expense Ratio
1.11%
Volatility
0.0 %
Fund House
Motilal Oswal Mutual Fund
Fund Manager
Key Features
Scheme description
Minimum Purchase Application Amount
Rs. 0.0 (plus in multiples of Rs. 0.0)

Entry Load
Not applicable
Exit Load
1%- If redeemed on or before 15 days from the date of allotment. Nil- If redeemed after 15 days from the date of allotment
Indicative Investment Horizon
5 Years and above
Asset Allocation
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4AssetsCash & Cash EquivalentsEquity
Fund Performance
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4FundFD
Fund₹ 10000
FD₹ 10600
Performance

Scheme Performance (%)

Data as on - 28-05-2025
Created with Highcharts 4.1.4ReturnsMotilal Oswal Nifty MidSmall Healthcare Index Fund-Regular Plan-GrowthNIFTY 100 Equal Weight TRIIndex FundYTD1 Month3 Month6 Month1 Year3 Years5 Years10 YearsSince Launch-100102030

Yearly Performance (%)

Created with Highcharts 4.1.4ValuesMotilal Oswal Nifty MidSmall Healthcare Index Fund-Regular Plan-GrowthNIFTY 100 Equal Weight TRIIndex Fund2016201720182019202020212022202320242025-10010203040
Investment Returns Calculator
Amount InvestedFund ValueProfitReturns
Fund70,00070,7687684.38
Benchmark---
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Peer Comparison
Scheme Name Inception Date 1 Year Return % 2 Year Return % 3 Year Return % 5 Year Return % 10 Year Return %
Motilal Oswal Nifty MidSmall Healthcare Index Fund-Regular Plan-Growth 19-11-2024 0.0 0.0 0.0 0.0 0.0
Kotak Nifty Financial Services Ex-Bank Index Fund - Regular Plan - Growth option 14-08-2023 23.25 0.0 0.0 0.0 0.0
Tata Nifty MidSmall Healthcare Index Fund - Regular Plan - Growth 26-04-2024 19.28 0.0 0.0 0.0 0.0
Tata Nifty Financial Services Index Fund - Regular Plan - Growth 01-04-2024 18.97 0.0 0.0 0.0 0.0
ICICI Prudential NASDAQ 100 Index Fund - Growth 01-10-2021 16.69 23.95 22.37 0.0 0.0
Portfolio Analysis
Portfolio as on 30-04-2025
Sector Allocation
SectorAllocation (%)
Healthcare100.12
Portfolio Holdings
CompanyHoldings (%)
MAX HEALTHCARE INSTITUTE LIMITED EQ14.88
LUPIN LIMITED EQ NEW F.V. RS.2/-9.23
FORTIS HEALTHCARE LIMITED. EQ6.51
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-6.27
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/-5.07
ALKEM LABORATORIES LIMITED EQ4.95
LAURUS LABS LIMITED EQ NEW FV RS. 2/-4.31
GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/-3.79
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/-3.55
Krishna Institute Of Medical Sciences Limited2.94
ABBOTT INDIA LIMITED EQ2.83
BIOCON LIMITED EQ2.64
SUVEN PHARMACEUTICALS LIMITED EQ2.63
PIRAMAL PHARMA LIMITED EQ2.37
GLAXOSMITHKLINE PHARMACEUTICALS LTD EQ2.23
SYNGENE INTERNATIONAL LIMITED EQ2.19
NARAYANA HRUDAYALAYA LIMITED EQ2.18
JB Chemicals & Pharmaceuticals Limited2.11
AJANTA PHARMA LIMITED EQ NEW FV RS. 2/-2.07
ASTER DM HEALTHCARE LIMITED EQ2.07
GLAND PHARMA LIMITED EQ NEW FV Re.1/-2.03
DR. LAL PATHLABS LIMITED EQ NEW FV RS. 10/-1.88
NEULAND LABORATORIES LIMITED EQ1.86
GLOBAL HEALTH LIMITED EQ1.82
POLY MEDICURE LIMITED EQ NEW FV RS. 5/-1.79
NATCO PHARMA LIMITED EQ NEW FV RS. 2/-1.39
RAINBOW CHILDRENS MEDICARE LIMITED EQ1.26
GRANULES INDIA LIMITED EQ NEW FV RE. 1/-1.2
PFIZER LIMITED EQ1.18
ALEMBIC PHARMACEUTICALS LIMITED EQ0.89
Net Receivables / (Payables)-0.11
Sector Allocation
Created with Highcharts 4.1.4Others
Portfolio Holdings
Created with Highcharts 4.1.4MAX HEALTHCARE INSTITUTE LIMITED EQLUPIN LIMITED EQ NEW F.V. RS.2/-FORTIS HEALTHCARE LIMITED. EQAUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-MANKIND PHARMA LIMITED EQ NEW FV RE. 1/-ALKEM LABORATORIES LIMITED EQLAURUS LABS LIMITED EQ NEW FV RS. 2/-GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/-IPCA LABORATORIES LIMITED EQ NEW FV RE .1/-Others